David Ramsay

David Ramsay
Kam Lake

Statements in Debates

Debates of , 16th Assembly, 4th Session (day 7)

Mr. Speaker, I would like to table a product information leaflet, Arepanrix, H1N1, ASO3-Adjuvanted H1N1 pandemic influenza vaccine located on the Health Canada site which was revised October 21, 2009. Thank you.

Debates of , 16th Assembly, 4th Session (day 7)

Thank you, Mr. Speaker. I’d be happy to share this information, this product information leaflet on Arepanrix with the Minister so that she can see what I’m talking about.

Again, my concern, Mr. Speaker, is there shouldn’t be any confusion out there publicly. People have to have this information. I’d like to see this summarized for people before they get a shot so they can see what has actually been done with that vaccine. Again, this is a question I asked earlier, but will the Minister look at providing people who are going to get the flu shot with a list of all the ingredients that’s in the...

Debates of , 16th Assembly, 4th Session (day 7)

Mr. Speaker, I asked specifically about the Arepanrix H1N1 vaccine. Again, this is very confusing for people, confusing for me, confusing for the general public, because if you go to the product information leaflet on Arepanrix H1N1 right off of the Health Canada website, it says right here in healthy adults, aged 18 to 60 years and no -- I repeat no -- clinical experience yet in elderly, in children or in adolescents. What they did is use a different testing model on children and adolescents and the elderly. They didn’t use this. This vaccine has not, to my knowledge off the Health Canada...

Debates of , 16th Assembly, 4th Session (day 7)

Mr. Speaker, the Minister forgot to say one of the ingredients on the list and that was formaldehyde. I would like to add that for her.

The other question I have, Mr. Speaker, on the Department of Health’s H1N1 flu site, it says at the end: “MYTH: because H1N1 vaccine is new, it is untested and unsafe. FACT:” -- and at the end of that statement it says -- “and no safety concerns have been found.” The reason, Mr. Speaker, I bring this up is because it is confusing for people out there when they do go to the Health Canada website and they see some of what are the side effects: very common; common...

Debates of , 16th Assembly, 4th Session (day 7)

Mr. Speaker, again, that is a nice story. I am glad people are getting their shot, but the question I had for the Minister was: at the multiplex today were there product information leaflets available to the public who are getting their shot that clearly indicates every ingredient in that vaccine, Mr. Speaker? By the sounds of it, people have to ask what is in it. I don’t think that is appropriate. I think that we should be providing the public with that type of information. I would like to ask the Minister, if that isn’t the case, if she could provide that level of information to our...

Debates of , 16th Assembly, 4th Session (day 7)

Thank you, Mr. Speaker. Today marks the first day of a mass vaccination against the spread of H1N1 -- Swine Flu -- in our Territory. Nationwide, this will be the largest mass vaccination and immunization program in Canadian history.

Like many parents, my wife and I find ourselves struggling over whether or not to give our two-year-old son this H1N1 vaccine. We’re even wondering, Mr. Speaker, whether or not we should get the shot ourselves.

I want to be clear that the Department of Health and Social Services is doing a great job at providing information about H1N1, and their website and public...

Debates of , 16th Assembly, 3rd Session (day 32)

Thank you, Mr. Speaker. I also seek unanimous consent to waive Rule 93(4) and have Committee Report 7-16(3) moved into Committee of the Whole for consideration today. Thank you.

---Unanimous consent granted.

Debates of , 16th Assembly, 3rd Session (day 32)

Thank you, Mr. Speaker. Your Standing Committee on Economic Development and Infrastructure is pleased to provide its report on the review of Bill 6, Species at Risk (NWT) Act and commends it to this House.

The Standing Committee on Economic Development and Infrastructure is pleased to report on its review of Bill 6, Species at Risk (NWT) Act.

Bill 6, Species at Risk (NWT) Act, set out the processes to identify, protect and recover species at risk in the NWT. The proposed act will apply to any wild animal, plant or other species managed by the Government of the Northwest Territories. It will...

Debates of , 16th Assembly, 3rd Session (day 32)

Sticking with the federal investment in our Territory and opportunities to do so, I’m wondering if the government has any proposals before the federal government on the Growing Forward Initiative, which is a $1.3 billion fund that the feds have set up to spearhead some investment in agriculture in this country.

Debates of , 16th Assembly, 3rd Session (day 32)

Thank you, Mr. Speaker. I have some questions today for the Premier. It goes back to my Member’s statement where I talked about the federal government and investing dollars in Northern Canada. I have to say, the other day I was really impressed that the Yukon government looks like they’re getting $71 million from the Government of Canada to invest in the Mayo hydro facility enhancement and stage 2 of the Carmacks-Stewart Transmission Line. It got me thinking whether or not our government has had any discussions with the federal government in terms of coming to the plate on the Taltson...